Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Profit After Tax (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Profit After Tax for 7 consecutive years, with -$83.3 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax rose 36.1% to -$83.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$113.7 million through Dec 2025, up 58.58% year-over-year, with the annual reading at -$113.7 million for FY2025, 58.58% up from the prior year.
  • Profit After Tax hit -$83.3 million in Q4 2025 for IDEAYA Biosciences, down from $119.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $119.2 million in Q3 2025 to a low of -$130.3 million in Q4 2024.
  • Historically, Profit After Tax has averaged -$30.5 million across 5 years, with a median of -$25.8 million in 2022.
  • Biggest five-year swings in Profit After Tax: plummeted 1799.07% in 2023 and later soared 330.11% in 2025.
  • Year by year, Profit After Tax stood at -$18.2 million in 2021, then tumbled by 32.88% to -$24.2 million in 2022, then tumbled by 40.3% to -$34.0 million in 2023, then crashed by 283.78% to -$130.3 million in 2024, then soared by 36.1% to -$83.3 million in 2025.
  • Business Quant data shows Profit After Tax for IDYA at -$83.3 million in Q4 2025, $119.2 million in Q3 2025, and -$77.5 million in Q2 2025.